Glucagon-like peptide-1 (GLP-1) agonists are a class of medications that have gained significant attention in recent years for their ability to manage blood sugar levels and promote weight loss. These drugs mimic the effects of the naturally occurring GLP-1 hormone, which is produced in the small intestine and plays a crucial role in regulating insulin secretion, glucose homeostasis, and appetite.

MEDICAL WEIGHT LOSS Tirzepatide: A Novel Weight Loss Medication 11 min read Updated May 31, 2024 Written By Eli Luft, PA-C Medically Reviewed by Dr. Paul Rivas Evidence-based Key Takeaways 1.Tirzepatide is a dual GIP and GLP-1 receptor agonist approved for chronic weight management in adults with obesity or overweight. 2.Clinical trials demonstrated remarkable weight loss with tirzepatide, up to 20.9% of body weight over 72 weeks. 3. Common side effects include gastrointestinal issues like nausea, diarrhea, and vomiting, which are generally mild to moderate. 4. Tirzepatide [...]